2025 Veterinary Anti-infectives Market Outlook: Key Indicators Shaping Growth Through 2034

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

What Will the Veterinary Anti-infectives Industry Market Size Be by 2025?
In the past few years, the veterinary anti-infectives market has experienced robust growth. It is predicted to surge from $5.54 billion in 2024 to $6.03 billion in 2025, with a compound annual growth rate (CAGR) of 8.9%. The growth during the historical period can be credited to a rise in pet ownership, the spread of infectious diseases, advancements in veterinary medicine, rising consciousness, and government initiatives.

What's the Long-Term Growth Forecast for the Veterinary Anti-infectives Market Size Through 2029?
The market size of veterinary anti-infectives is anticipated to undergo substantial expansion in the coming years. It is projected to reach $8.74 billion in 2029, growing at a compound annual growth rate (CAGR) of 9.7%. This expansion during the forecast period can be credited to the steady rise in the pet population, the emergence of zoonotic illnesses, the globalization of the pet trade, and the increasing expenditure on veterinary healthcare. Notable trends during the forecast period comprise of technological progress, rising use of biologicals, the incorporation of telehealth into veterinary services, a shift towards natural and herbal alternatives, the growth of e-commerce in veterinary pharmaceuticals, along with collaborations and partnerships.

View the full report here:
https://www.thebusinessresearchcompany.com/report/veterinary-anti-infectives-global-market-report

What Are the Key Growth Drivers Fueling the Veterinary Anti-infectives Market Expansion?
The upward trend in the number of individuals owning pets is set to fuel the expansion of the veterinary anti-infectives market. Owning a pet, whether it's a dog, cat, or any other household pet, is what dictates pet ownership. An increasing number of today's younger generation are integrating pets into their families, adopting them out of companionship, loyalty, and a desire for company. For example, Animal Medicines Australia, a non-governmental organization located in Australia, noted a noticeable rise in pet ownership in 2022. The number of individuals owning pets in Australia escalated to 28,730.8 in 2022, a growth of 24% from the previous year's 39%. This surging demand exemplifies the escalating trend of pet adoption and spending on pet care, and the rising acceptance of pets in Australian homes. Consequently, the growing numbers of pet owners is catalyzing demand in the veterinary anti-infectives market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7802&type=smp

What Are the Key Trends Driving Veterinary Anti-infectives Market Growth?
A significant trend escalating in the veterinary anti-infectives market is the evolution of technological advancements. Leading corporations in the sector are employing cutting-edge technology to maintain their foothold in this market. For instance, Elanco Animal Health Incorporated, an American pharmaceutical entity that produces drugs and vaccines for pets and livestock, unveiled Increxxa in February 2022. This new drug has been approved for the treatment of respiratory diseases in livestock. The main component of Increxxa is tulathromycin, which is administered to the livestock via injection, promptly targets the lungs, the site of infection, for rapid action and a prolonged half-life. This paves the way for a more robust defense mechanism in the cattle. Specifically formulated for veterinary applications, the active constituent of Increxxa, tulathromycin, aids in mitigating the adverse ramifications of bovine respiratory disease.

How Is the Veterinary Anti-infectives Market Segmented?
The veterinary anti-infectives market covered in this report is segmented -

1) By Drug Class: Antimicrobial Agents, Antiviral Agents, Antifungal Agents, Other Drug Classes
2) By Species Type: Livestock Animals, Companion Animals
3) By Mode Of Administration: Oral, Parenteral, Topical
4) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Pharmacies, Others Distribution Channels

Subsegments:
1) By Antimicrobial Agents: Antibiotics, Antiseptics
2) By Antiviral Agents: Vaccines, Antiviral Medications
3) By Antifungal Agents: Topical Antifungals, Systemic Antifungals
4) By Other Drug Classes: Parasiticides, Immune Modulators, Disinfectants

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=7802&type=smp

Which Companies Are Leading the Charge in Veterinary Anti-infectives Market Innovation?
Major companies operating in the veterinary anti-infectives market include Bayer AG, C. H. Boehringer Sohn AG & Co. KG, Ceva Santé Animale, Elanco Animal Health Incorporated, Zoetis Inc., Vetoquinol S. A., Merck & Co., Phibro Animal Health, Aspen Veterinary Resources Ltd., Bimeda Animal Health Limited, Dechra Pharmaceuticals Plc, Intervet International B. V., Oceanic Pharmachem Pvt. Ltd., Virbac Ltd., Indian Immunologicals Ltd. (IIL), Norbrook Laboratories Ltd., Ashish Life Science Pvt. Ltd., Kyoritsu Seiyaku Corporation, Tianjin Ringpu Bio-Technology Co. Ltd., HIPRA, Zydus Animal Health and Investments Limited, China Animal Husbandry Group, ZOOVETVARU Ltd., Magnum Veterinaaria Ltd., Inovet (V. M. D. nv/sa), Chanelle Pharmaceuticals Manufacturing Ltd., Huvepharma Inc., Veyx Pharma GmbH, Biovet Pvt. Ltd., Laboratorios Ovejero SA, Laboratorios Syva S. A.

Which Regions Are Leading the Global Veterinary Anti-infectives Market in Revenue?
North America was the largest region in the veterinary anti-infectives market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary anti-infectives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7802

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.